DOA
BSX icon

D'Orazio & Associates’s Boston Scientific BSX Stock Holding History

D'Orazio & Associates’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,199
Closed -$210K – 304
2025
Q4 		$210K Sell
2,199
-185
-8% -$18.1K 0.03% 256
2025
Q3 		$233K Sell
2,384
-91
-4% -$9.42K 0.03% 229
2025
Q2 		$266K Buy
2,475
+86
+4% +$8.7K 0.04% 191
2025
Q1 		$241K Buy
+2,389
New +$241K 0.04% 197
2016
Q3 		– Sell
-300
Closed -$7K – 283
2016
Q2 		$7K Hold
300
– – ﹤0.01% 229
2016
Q1 		$5K Buy
+300
New +$5.27K ﹤0.01% 246

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

D'Orazio & Associates's BSX Position: Q1 2026 in Review

D'Orazio & Associates sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 2,199 shares — an estimated $210K sold.

D'Orazio & Associates first reported a position in BSX in Q1 2016 and held it in 6 quarters. The position peaked at $266K in Q2 2025. 1,682 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • D'Orazio & Associates reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • D'Orazio & Associates sold 2,199 Boston Scientific shares in Q1 2026, an estimated $210K.
  • D'Orazio & Associates first reported a position in Boston Scientific in Q1 2016 and held it in 6 quarters.
  • D'Orazio & Associates's Boston Scientific position peaked at $266K in Q2 2025.
  • 1,682 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on D'Orazio & Associates's 13F filing for Q1 2026, filed 7 May 2026.